| 研究生: |
許嘉舫 Hsu, Chia-Fang |
|---|---|
| 論文名稱: |
骨骼肌健康及身體表現預測化學治療後婦癌病人症狀困擾 Skeletal Muscle Health and Physical Performance Predict the Chemotherapy Symptom Distress in Women with Gynecological Cancer |
| 指導教授: |
許玉雲
Hsu, Yu-Yun |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 護理學系 Department of Nursing |
| 論文出版年: | 2025 |
| 畢業學年度: | 113 |
| 語文別: | 中文 |
| 論文頁數: | 102 |
| 中文關鍵詞: | 骨骼肌健康 、身體表現 、症狀困擾 、婦癌 、化學治療 |
| 外文關鍵詞: | Skeletal muscle health, Physical performance, Symptom distress, Gynecological cancer, Chemotherapy |
| 相關次數: | 點閱:101 下載:0 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
阮瓊慧.(2010).乳癌術後輔助性化學治療病人之症狀群集〔未出版之碩士論文〕.高雄醫學大學。
張瑩如.(2023).症狀管理理論在研究及實務的應用.源遠護理,17(3), 5-9。https://doi.org/10.6530/yyn.202311_17(3).0001
臺灣癌症臨床研究合作組織婦癌工作群編撰小組.(2011).婦癌臨床診療指引.國家衛生研究院。https///tcog.nhri.edu.tw/wp-content/uploads/2020/05/100gogpg.pdf
衛生福利部國民健康署.(2024).111年癌症登記年報。https://www.hpa.gov.tw/File/Attach/18683/File_25342.pdf
Anker, M. S., Lena, A., Roeland, E. J., Porthun, J., Schmitz, S., Hadzibegovic, S., Sikorski, P., Wilkenshoff, U., Fröhlich, A. K., Ramer, L. V., Rose, M., Eucker, J., Rassaf, T., Totzeck, M., Lehmann, L. H., von Haehling, S., Coats, A. J. S., Friede, T., Butler, J.,…Ahn, J. (2023). Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer. Journal Cachexia Sarcopenia Muscle Journal of Cachexia, Sarcopenia and Muscle, 14(4), 1670-1681. https://doi.org/10.1002/jcsm.13247
Antunes, P., Joaquim, A., Sampaio, F., Nunes, C., Ascensão, A., Vilela, E., Teixeira, M., Oliveira, J., Capela, A., Amarelo, A., Leão, I., Marques, C., Viamonte, S., Alves, A., & Esteves, D. (2024). Exercise training benefits health-related quality of life and functional capacity during breast cancer chemotherapy: a randomized controlled trial. Medicine and Science in Sports and Exercise, 56(4), 600-611. https://doi.org/10.1249/mss.0000000000003341
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2015). Cachexia and sarcopenia: mechanisms and potential targets for intervention. Current Opinion in Pharmacology, 22, 100-106. https://doi.org/10.1016/j.coph.2015.04.003
Aust, S., Knogler, T., Pils, D., Obermayr, E., Reinthaller, A., Zahn, L., Radlgruber, I., Mayerhoefer, M. E., Grimm, C., & Polterauer, S. (2015). Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer. PLoS One, 10(10), e0140403. https://doi.org/10.1371/journal.pone.0140403
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018). Cancer-associated cachexia. Nature Reviews. Disease Primers, 4, 17105. https://doi.org/10.1038/nrdp.2017.105
Bennett, J. A., Lyons, K. S., Winters-Stone, K., Nail, L. M., & Scherer, J. (2007). Motivational interviewing to increase physical activity in long-term cancer survivors: a randomized controlled trial. Nursing Research, 56(1), 18-27. https://doi.org/10.1097/00006199-200701000-00003
Benton, M. J., Spicher, J. M., & Silva-Smith, A. L. (2022). Validity and reliability of handgrip dynamometry in older adults: A comparison of two widely used dynamometers. PLoS One, 17(6), e0270132. https://doi.org/10.1371/journal.pone.0270132
Bohannon, R. W., Kindig, J., Sabo, G., Duni, A. E., & Cram, P. (2012). Isometric knee extension force measured using a handheld dynamometer with and without belt-stabilization. Physiother Theory Pract, 28(7), 562-568. https://doi.org/10.3109/09593985.2011.640385
Bruno, K. A., Sobreira da Silva, M. J., & Chaves, G. V. (2021). Association of body composition with toxicity to first-line chemotherapy and three-year survival in women with ovarian adenocarcinoma. Acta Oncologica (Stockholm, Sweden), 60(12), 1611-1620. https://doi.org/10.1080/0284186x.2021.1983210
Buckinx, F., Croisier, J. L., Reginster, J. Y., Dardenne, N., Beaudart, C., Slomian, J., Leonard, S., & Bruyère, O. (2017). Reliability of muscle strength measures obtained with a hand-held dynamometer in an elderly population. Clinical Physiology And Functional Imaging, 37(3), 332-340. https://doi.org/10.1111/cpf.12300
Calvo-Schimmel, A., Hammer, M. J., Wright, A. A., Blank, S. V., Cohen, B., Harris, C., Shin, J., Conley, Y., Paul, S., Cooper, B., Levine, J. D., & Miaskowski, C. (2024). Worse depression profiles are associated with higher symptom burden and poorer quality of life in patients with gynecologic cancer. Cancer Nursing, 47(6), E404-e414. https://doi.org/10.1097/ncc.0000000000001296
Cavaletti, G., D’Acunti, A., Porcu, A., Masiello, G., Del Campo, L., Traclò, G., De Lorenzo, F., & Bernasconi, D. P. (2023). Self-reported assessment of the socio-economic impact of anticancer chemotherapy-related neurotoxicity. Toxics, 11(2), Article 104. https://doi.org/10.3390/toxics11020104
Cesari, M., Cerullo, F., Zamboni, V., Di Palma, R., Scambia, G., Balducci, L., Antonelli Incalzi, R., Vellas, B., & Gambassi, G. (2013). Functional status and mortality in older women with gynecological cancer. The Journals of Gerontology. Series A, Biological Sciences And Medical Sciences, 68(9), 1129-1133. https://doi.org/10.1093/gerona/glt073
Cesari, M., Kritchevsky, S. B., Newman, A. B., Simonsick, E. M., Harris, T. B., Penninx, B. W., Brach, J. S., Tylavsky, F. A., Satterfield, S., Bauer, D. C., Rubin, S. M., Visser, M., & Pahor, M. (2009). Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. Journal of the American Geriatrics Society, 57(2), 251-259. https://doi.org/10.1111/j.1532-5415.2008.02126.x
Chae, S. H., Lee, C., Yoon, S. H., Shim, S. H., Lee, S. J., Kim, S. N., Chung, S., & Lee, J. Y. (2021). Sarcopenia as a predictor of prognosis in early stage ovarian cancer. Journal of Korean Medical Science, 36(1), e2. https://doi.org/10.3346/jkms.2021.36.e2
Chang, V. T., Hwang, S. S., Feuerman, M., Kasimis, B. S., & Thaler, H. T. (2000). The memorial symptom assessment scale short form (MSAS-SF). Cancer, 89(5), 1162-1171. https://doi.org/10.1002/1097-0142(20000901)89:5<1162::aid-cncr26>3.0.co;2-y
Chase, D. M., Huang, H., Foss, C. D., Wenzel, L. B., Monk, B. J., & Burger, R. A. (2015). Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology, 136(2), 323-327. https://doi.org/10.1016/j.ygyno.2014.12.021
Chen, L. K., Liu, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Bahyah, K. S., Chou, M. Y., Chen, L. Y., Hsu, P. S., Krairit, O., Lee, J. S., Lee, W. J., Lee, Y., Liang, C. K., Limpawattana, P., Lin, C. S., Peng, L. N., Satake, S., Suzuki, T.,…Arai, H. (2014). Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. Journal of the American Medical Directors Association, 15(2), 95-101. https://doi.org/10.1016/j.jamda.2013.11.025
Chung, C. W. (2006). Longitudinal study on the profiles of symptom distress and functional status in gynecologic cancer patients receiving chemotherapy. Korean Journal of Women Health Nursing, 12(1), 53-60. https://doi.org/10.4069/kjwhn.2006.12.1.53
Cieza, A., Causey, K., Kamenov, K., Hanson, S. W., Chatterji, S., & Vos, T. (2021). Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 396(10267), 2006-2017. https://doi.org/10.1016/s0140-6736(20)32340-0
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., & Zamboni, M. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169
Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E. S., Humphreys, J., Lee, K., Miaskowski, C., Puntillo, K., Rankin, S., & Taylor, D. (2001). Advancing the science of symptom management. Journal of Advanced Nursing, 33(5), 668-676. https://doi.org/10.1046/j.1365-2648.2001.01697.x
Feng, Y., Lin, T., Liu, X., Guo, X., Chen, J., & Deng, X. (2024). A longitudinal study of symptom cluster latent profiles in ovarian cancer patients undergoing chemotherapy. Cancer Medicine, 13(7), e7139. https://doi.org/10.1002/cam4.7139
Frontera, W. R., & Ochala, J. (2015). Skeletal muscle: a brief review of structure and function. Calcified Tissue International, 96(3), 183-195. https://doi.org/10.1007/s00223-014-9915-y
Ge, H. P., Song, D. F., Wu, P., & Xu, H. F. (2023). Impact of sarcopenia and low muscle attenuation on outcomes of ovarian cancer: a systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences, 27(10), 4544-4562. https://doi.org/10.26355/eurrev_202305_32461
Gilliam, L. A., & St Clair, D. K. (2011). Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxidants & Redox Signaling, 15(9), 2543-2563. https://doi.org/10.1089/ars.2011.3965
Griffin, O. M., Duggan, S. N., Ryan, R., McDermott, R., Geoghegan, J., & Conlon, K. C. (2019). Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. Pancreatology, 19(6), 850-857. https://doi.org/10.1016/j.pan.2019.07.039
Grootswagers, P., Vaes, A. M. M., Hangelbroek, R., Tieland, M., van Loon, L. J. C., & de Groot, L. (2022). Relative validity and reliability of isometric lower extremity strength assessment in older adults by using a handheld dynamometer. Sports Health, 14(6), 899-905. https://doi.org/10.1177/19417381211063847
Grusdat, N. P., Stäuber, A., Tolkmitt, M., Schnabel, J., Schubotz, B., Wright, P. R., & Schulz, H. (2022). Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. Support Care Cancer, 30(5), 3733-3744. https://doi.org/10.1007/s00520-021-06787-5
Guigni, B. A., Callahan, D. M., Tourville, T. W., Miller, M. S., Fiske, B., Voigt, T., Korwin-Mihavics, B., Anathy, V., Dittus, K., & Toth, M. J. (2018). Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress. American Journal of Physiology. Cell Physiology, 315(5), C744-c756. https://doi.org/10.1152/ajpcell.00002.2018
Hammer, M. J., Cooper, B., Paul, S. M., Kober, K. M., Cartwright, F., Conley, Y. P., Wright, F., Levine, J. D., & Miaskowski, C. (2022). Identification of distinct symptom profiles in cancer patients using a pre-specified symptom cluster. Journal of Pain and Symptom Management, 64(1), 17-27. https://doi.org/10.1016/j.jpainsymman.2022.03.007
Hammer, M. J., Cooper, B. A., Chen, L. M., Wright, A. A., Pozzar, R., Blank, S. V., Cohen, B., Dunn, L., Paul, S., Conley, Y. P., Levine, J. D., & Miaskowski, C. (2023). Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster. Supportive Care in Cancer, 31(8), Article 485. https://doi.org/10.1007/s00520-023-07954-6
Hanna, L., Nguo, K., Furness, K., Porter, J., & Huggins, C. E. (2022). Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 13(2), 839-857. https://doi.org/10.1002/jcsm.12928
Hantel, A., DuMontier, C., Odejide, O. O., Luskin, M. R., Sperling, A. S., Hshieh, T., Chen, R., Soiffer, R., Driver, J. A., & Abel, G. A. (2021). Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer, 127(6), 875-883. https://doi.org/10.1002/cncr.33344
Hawley, S. E., Bell, Z. W., Huang, Y., Gibbs, J. C., & Churchward-Venne, T. A. (2023). Evaluation of sex-based differences in resistance exercise training-induced changes in muscle mass, strength, and physical performance in healthy older (≥60 y) adults: A systematic review and meta-analysis. Ageing Research Reviews, 91, 102023. https://doi.org/10.1016/j.arr.2023.102023
Hoffmann, C., & Weigert, C. (2017). Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harbor Perspectives in Medicine, 7(11). https://doi.org/10.1101/cshperspect.a029793
Hossain, M. B., & Haldar Neer, A. H. (2023). Chemotherapy. In Cancer Treatment and Research (Vol. 185, pp. 49-58). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-031-27156-4_3
Hsu, W. H., Ko, A. T., Weng, C. S., Chang, C. L., Jan, Y. T., Lin, J. B., Chien, H. J., Lin, W. C., Sun, F. J., Wu, K. P., & Lee, J. (2023). Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer. Journal of Cachexia, Sarcopenia and Muscle, 14(5), 2044-2053. https://doi.org/10.1002/jcsm.13282
Hui, D., & Bruera, E. (2017). The edmonton symptom assessment system 25 years later: past, present, and future developments. Journal of Pain and Symptom Management, 53(3), 630-643. https://doi.org/10.1016/j.jpainsymman.2016.10.370
Husebø, A. M., Dyrstad, S. M., Mjaaland, I., Søreide, J. A., & Bru, E. (2014). Effects of scheduled exercise on cancer-related fatigue in women with early breast cancer. The Scientific World Journal, 2014, 271828. https://doi.org/10.1155/2014/271828
Institute, N. C. (Ud). symptom. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/symptom
Jang, M. K., Park, C., Hong, S., Li, H., Rhee, E., & Doorenbos, A. Z. (2020). Skeletal muscle mass change during chemotherapy: a systematic review and meta-analysis. Anticancer Research, 40(5), 2409-2418. https://doi.org/10.21873/anticanres.14210
Jarvis, L. M., Peterson, M. J., & Caves, K. M. (2021). Development, validity, and reliability of a novel walking speed measurement device: the Gaitbox. Gait & Posture, 84, 52-57. https://doi.org/10.1016/j.gaitpost.2020.11.009
Jin, Y., Ma, X., Yang, Z., & Zhang, N. (2023). Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis. Journal of Cachexia Sarcopenia Muscle, 14(2), 697-705. https://doi.org/10.1002/jcsm.13175
Jun Su Park, H. N., Hyebin Lee, Woo Young Kim. (2021). Clinical impact of sarcopenia in patients with uterine cervical cancer treated with radiotherapy. European Journal of Gynaecological Oncology, 42(3), 567-573. https://doi.org/10.31083/j.ejgo.2021.03.2356
Kallen, M., Slotkin, J., Griffith, J., Magasi, S., Salsman, J., Nowinski, C., & Gershon, R. (2012). Domain and subdomain: motor, locomotion. In NIH Toolbox Technical Manual. NIH. https://www.healthmeasures.net/images/nihtoolbox/Technical_Manuals/Motor/Toolbox_4-Meter_Walk_Gait_Speed_Test_Technical_Manual.pdf
Kimura, M., Naito, T., Kenmotsu, H., Taira, T., Wakuda, K., Oyakawa, T., Hisamatsu, Y., Tokito, T., Imai, H., Akamatsu, H., Ono, A., Kaira, K., Murakami, H., Endo, M., Mori, K., Takahashi, T., & Yamamoto, N. (2015). Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer, 23(6), 1699-1708. https://doi.org/10.1007/s00520-014-2534-3
Kittelson, A., Carmichael, J., Stevens-Lapsley, J., & Bade, M. (2022). Psychometric properties of the 4-meter walk test after total knee arthroplasty. Disability and Rehabilitation, 44(13), 3204-3210. https://doi.org/10.1080/09638288.2020.1852446
Knapp, T. R. (2018). Symptom: cause, effect, both, or neither? Clinical Nursing Research, 27(4), 391-394. https://doi.org/10.1177/1054773818761904
Lee, J. B., Sung, B. J., Ko, B. G., Cho, E. H., & Seo, T. B. (2023). A comparative study on the reliability and validity of body composition results by impedance method measurement device. Journal of Exercise Rehabilitation, 19(5), 299-308. https://doi.org/10.12965/jer.2346404.202
Liddell, H. G., & Scott, R. (2011). A Greek-English lexicon. Perseus.tufts.edu. https://www.perseus.tufts.edu/hopper/text?doc=Perseus%3Atext%3A1999.04.0057%3Aentry%3D%2398870&redirect=true
Ligibel, J. A., Meyerhardt, J., Pierce, J. P., Najita, J., Shockro, L., Campbell, N., Newman, V. A., Barbier, L., Hacker, E., Wood, M., Marshall, J., Paskett, E., & Shapiro, C. (2012). Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting. Breast Cancer Research and Treatment, 132(1), 205-213. https://doi.org/10.1007/s10549-011-1882-7
Lin, W. L., Nguyen, T. H., Lin, C. Y., Wu, L. M., Huang, W. T., & Guo, H. R. (2022). Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis. Frontiers in Oncology, 12, 1037796. https://doi.org/10.3389/fonc.2022.1037796
Liu, M. A., DuMontier, C., Murillo, A., Hshieh, T. T., Bean, J. F., Soiffer, R. J., Stone, R. M., Abel, G. A., & Driver, J. A. (2019). Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies. Blood, 134(4), 374-382. https://doi.org/10.1182/blood.2019000758
Liu, R., Gao, X. Y., & Wang, L. (2024). Network meta-analysis of the intervention effects of different exercise measures on Sarcopenia in cancer patients. BMC Public Health, 24(1), 1281. https://doi.org/10.1186/s12889-024-18493-y
Luo, J., Yao, W., Zhang, T., Ge, H., & Zhang, D. (2021). Exploring the bidirectional associations between handgrip strength and depression in middle and older Americans. Journal of Psychosomatic Research, 152, 110678. https://doi.org/10.1016/j.jpsychores.2021.110678
McClement, S. E., Woodgate, R. L., & Degner, L. (1997). Symptom distress in adult patients with cancer. Cancer Nursing, 20(4). https://journals.lww.com/cancernursingonline/fulltext/1997/08000/symptom_distress_in_adult_patients_with_cancer.2.aspx
McCorkle, R., & Young, K. (1978). Development of a symptom distress scale. Cancer Nursing, 1(5), 373-378.
Miles, A., McClements, P. L., Steele, R. J., Redeker, C., Sevdalis, N., & Wardle, J. (2017). Perceived diagnostic delay and cancer-related distress: a cross-sectional study of patients with colorectal cancer. Psychooncology, 26(1), 29-36. https://doi.org/10.1002/pon.4093
Olpe, T., Wunderle, C., Bargetzi, L., Tribolet, P., Laviano, A., Stanga, Z., Prado, C. M., Mueller, B., & Schuetz, P. (2024). Muscle matters: Prognostic implications of malnutrition and muscle health parameters in patients with cancer. A secondary analysis of a randomised trial. Clinical Nutrition (Edinburgh, Scotland), 43(9), 2255-2262. https://doi.org/10.1016/j.clnu.2024.07.020
Oo, T. T., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2022). Emerging roles of toll-like receptor 4 in chemotherapy-induced neurotoxicity. NeuroToxicology, 93, 112-127. https://doi.org/10.1016/j.neuro.2022.09.006
Oppegaard, K., Harris, C. S., Shin, J., Paul, S. M., Cooper, B. A., Levine, J. D., Conley, Y. P., Hammer, M., Cartwright, F., Wright, F., Dunn, L., Kober, K. M., & Miaskowski, C. (2021). Anxiety profiles are associated with stress, resilience and symptom severity in outpatients receiving chemotherapy. Support Care Cancer, 29(12), 7825-7836. https://doi.org/10.1007/s00520-021-06372-w
Orsso, C. E., Caretero, A., Poltronieri, T. S., Arends, J., de van der Schueren, M. A., Kiss, N., Laviano, A., & Prado, C. M. (2024). Effects of high-protein supplementation during cancer therapy: a systematic review and meta-analysis. The American Journal of Clinical Nutrition, 120(6), 1311-1324. https://doi.org/10.1016/j.ajcnut.2024.08.016
Ostir, G. V., Kuo, Y. F., Berges, I. M., Markides, K. S., & Ottenbacher, K. J. (2007). Measures of lower body function and risk of mortality over 7 years of follow-up. American Journal of Epidemiology, 166(5), 599-605. https://doi.org/10.1093/aje/kwm121
Oswald, L. B., Eisel, S. L., Tometich, D. B., Bryant, C., Hoogland, A. I., Small, B. J., Apte, S. M., Chon, H. S., Shahzad, M. M., Gonzalez, B. D., & Jim, H. S. L. (2022). Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy. Health Psychology, 41(11), 864-873. https://doi.org/10.1037/hea0001190
Padilha, C. S., Marinello, P. C., Galvão, D. A., Newton, R. U., Borges, F. H., Frajacomo, F., & Deminice, R. (2017). Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis. Journal of Cancer Survivorship, 11(3), 339-349. https://doi.org/10.1007/s11764-016-0592-x
Patel, K. V., Guralnik, J. M., Phelan, E. A., Gell, N. M., Wallace, R. B., Sullivan, M. D., & Turk, D. C. (2019). Symptom burden among community-dwelling older adults in the United States. Journal of the American Geriatrics Society, 67(2), 223-231. https://doi.org/10.1111/jgs.15673
Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews. Endocrinology, 8(8), 457-465. https://doi.org/10.1038/nrendo.2012.49
Peters, D. M., Fritz, S. L., & Krotish, D. E. (2013). Assessing the reliability and validity of a shorter walk test compared with the 10-Meter Walk Test for measurements of gait speed in healthy, older adults. Journal of Geriatric Physical Therapy, 36(1), 24-30. https://doi.org/10.1519/JPT.0b013e318248e20d
Phianmongkhol, Y., & Suwan, N. (2008). Symptom management in patients with cancer of the female reproductive system receiving chemotherapy [Article]. Asian Pacific Journal of Cancer Prevention, 9(4), 741-745. https://www.scopus.com/inward/record.uri?eid=2-s2.0-66149116450&partnerID=40&md5=5cb43dc24a3301caa4338cedc7c613bb
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., Sobel, K., Coyle, N., Kemeny, N., Norton, L., & et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European journal of cancer (Oxford, England : 1990), 30a(9), 1326-1336. https://doi.org/10.1016/0959-8049(94)90182-1
Rhodes, V. A., & Watson, P. M. (1987). Symptom distress—The concept: Past and present. Seminars in Oncology Nursing, 3(4), 242-247. https://doi.org/https://doi.org/10.1016/S0749-2081(87)80014-1
Rier, H. N., Jager, A., Sleijfer, S., van Rosmalen, J., Kock, M., & Levin, M. D. (2018). Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer. Breast Cancer Research and Treatment, 168(1), 95-105. https://doi.org/10.1007/s10549-017-4574-0
Roy, M. A., & Doherty, T. J. (2004). Reliability of hand-held dynamometry in assessment of knee extensor strength after hip fracture. American Journal of Physical Medicine & Rehabilitation, 83(11), 813-818. https://doi.org/10.1097/01.phm.0000143405.17932.78
Sailors, M. H., Bodurka, D. C., Gning, I., Ramondetta, L. M., Williams, L. A., Mendoza, T. R., Agarwal, S., Sun, C. C., & Cleeland, C. S. (2013). Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecologic Oncology, 130(2), 323-328. https://doi.org/10.1016/j.ygyno.2013.05.009
Sasani, K., Catanese, H. N., Ghods, A., Rokni, S. A., Ghasemzadeh, H., Downey, R. J., & Shahrokni, A. (2019). Gait speed and survival of older surgical patient with cancer: Prediction after machine learning. Journal of Geriatric Oncology, 10(1), 120-125. https://doi.org/10.1016/j.jgo.2018.06.012
Schmidt, M. E., Wiskemann, J., & Steindorf, K. (2018). Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27(8), 2077-2086. https://doi.org/10.1007/s11136-018-1866-8
Scripture, C. D., Figg, W. D., & Sparreboom, A. (2006). Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives. Current Neuropharmacology, 4(2), 165-172. https://doi.org/10.2174/157015906776359568
Severinsen, M. C. K., & Pedersen, B. K. (2020). Muscle-organ crosstalk: the emerging roles of myokines. Endocrine Reviews, 41(4), 594-609. https://doi.org/10.1210/endrev/bnaa016
Shin, J., Harris, C., Oppegaard, K., Kober, K. M., Paul, S. M., Cooper, B. A., Hammer, M., Conley, Y., Levine, J. D., & Miaskowski, C. (2022). Worst pain severity profiles of oncology patients are associated with significant stress and multiple co-occurring symptoms. The Journal of Pain, 23(1), 74-88. https://doi.org/10.1016/j.jpain.2021.07.001
Siedler, M. R., Rodriguez, C., Stratton, M. T., Harty, P. S., Keith, D. S., Green, J. J., Boykin, J. R., White, S. J., Williams, A. D., DeHaven, B., & Tinsley, G. M. (2023). Assessing the reliability and cross-sectional and longitudinal validity of fifteen bioelectrical impedance analysis devices. The British Journal of Nutrition, 130(5), 827-840. https://doi.org/10.1017/s0007114522003749
Sorensen, J. C., Cheregi, B. D., Timpani, C. A., Nurgali, K., Hayes, A., & Rybalka, E. (2016). Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? Cancer Chemotherapy and Pharmacology, 78(4), 673-683. https://doi.org/10.1007/s00280-016-3045-3
Sorrera, D., Block, A., Mackin, L., Paul, S. M., Cooper, B. A., Hammer, M. J., Conley, Y. P., Levine, J. D., & Miaskowski, C. (2023). Decrements in both physical and cognitive function are associated with a higher symptom burden in oncology patients. Seminars in Oncology Nursing, 39(6), 151516. https://doi.org/10.1016/j.soncn.2023.151516
Stapleton, S. J., Holden, J., Epstein, J., & Wilkie, D. J. (2016). A systematic review of the symptom distress scale in advanced cancer studies. Cancer Nursing, 39(4), E9-e23. https://doi.org/10.1097/ncc.0000000000000292
Studenski, S., Perera, S., Patel, K., Rosano, C., Faulkner, K., Inzitari, M., Brach, J., Chandler, J., Cawthon, P., Connor, E. B., Nevitt, M., Visser, M., Kritchevsky, S., Badinelli, S., Harris, T., Newman, A. B., Cauley, J., Ferrucci, L., & Guralnik, J. (2011). Gait speed and survival in older adults. Jama, 305(1), 50-58. https://doi.org/10.1001/jama.2010.1923
Teran-Wodzinski, P., Haladay, D., Vu, T., Ji, M., Coury, J., Adams, A., Schwab, L., & Visovsky, C. (2022). Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial. Trials, 23(1), 363. https://doi.org/10.1186/s13063-022-06294-w
Tuğral, A., Arıbaş, Z., Akyol, M., & Bakar, Y. (2023). Assessment of sensorimotor and strength related function of breast cancer patients during systemic drug therapy: a prospective observational study. BMC Cancer, 23(1), 981. https://doi.org/10.1186/s12885-023-11494-x
Tuncer, M. (2022). Chemobrain: mysteries and the importance of their revelation. Hacettepe University Journal of the Faculty of Pharmacy, 42(4), 257-275. https://doi.org/10.52794/hujpharm.1100269
Unver, B., Baris, R. H., Yuksel, E., Cekmece, S., Kalkan, S., & Karatosun, V. (2017). Reliability of 4-meter and 10-meter walk tests after lower extremity surgery. Disability and Rehabilitation, 39(25), 2572-2576. https://doi.org/10.1080/09638288.2016.1236153
van der Zanden, V., van Soolingen, N. J., Viddeleer, A. R., Trum, J. W., Amant, F., Mourits, M. J. E., Portielje, J. E. A., Baalbergen, A., Souwer, E. T. D., & van Munster, B. C. (2022). Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications. European Journal of Surgical Oncology, 48(4), 896-902. https://doi.org/https://doi.org/10.1016/j.ejso.2021.10.015
Wei, C.-W., Liang, S.-Y., Chin, C.-H., Lin, H.-C., & Rosenberg, J. (2023). Change trajectory of symptom distress, coping strategies, and spiritual wellbeing in colorectal cancer patients undergoing chemotherapy. Healthcare, 11(6), 857. https://www.mdpi.com/2227-9032/11/6/857
Whittum, M., Yasukawa, M., Yoo, H. J., Jeong, D., Whiting, J., & Chon, H. S. (2023). Low muscle radiodensity as a predictor of chemotherapy-induced peripheral neuropathy in epithelial ovarian cancer patients (1154). Gynecologic Oncology, 176, S108. https://doi.org/10.1016/j.ygyno.2023.06.074
WHO. (2022). Musculoskeletal Health. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions
Yeh, Y. C. (2021). Symptom distress, stress, and quality of life in the first year of gynaecological cancers: A longitudinal study of women in Taiwan. European Journal of Oncology Nursing, 53, Article 101984. https://doi.org/10.1016/j.ejon.2021.101984
校內:2030-07-31公開